Corporate News Blog - Marathon Patent Group Shares Latest Developments on Debt Restructuring with Shareholders
Research Desk Line-up: First Data Post Earnings Coverage
LONDON, UK / ACCESSWIRE / August 17, 2017 /Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Marathon Patent Group, Inc. (NASDAQ: MARA) ("MARA"), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=MARA. On August 15, 2017, Doug Croxall, Marathon Patent Group's CEO, addressed the Company's shareholders in a direct communication. The communication to the shareholders provided detailed updates about the steps taken by MARA on debt restructuring and related developments taking place within the Company in recent times. For immediate access to our complimentary reports, including today's coverage, register for free now at:
Discover more of our free reports coverage from other companies within the Business Services industry. Pro-TD has currently selected First Data Corporation (NYSE: FDC) for due-diligence and potential coverage as the Company reported on August 07, 2017, its financial results for Q2 2017 which ended on June 30, 2017. Tune in to our site to register for a free membership, and be among the early birds that get our report on First Data when we publish it.
At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on MARA; also brushing on FDC. Go directly to your stock of interest and access today's free coverage at:
Restructuring agreement with DBD Credit Funding
Doug disclosed that MARA had entered into a Restructuring Agreement with DBD Credit Funding on August 03, 2017. As per the agreement, MARA will offer three of its most promising portfolios to DBD. The three portfolios to be transferred to DBD are Magnus IP, Traverse Technologies, and Dynamic Advances. In return DBD would take over MARA's existing debt obligation of approximately $16 million. The entire debt will be taken over by a new entity formed and controlled by DBD. As a result, MARA will be able to retire 100% of its long-term debt. Apart from this, MARA will also be free of any funding obligations towards the three portfolios transferred to DBD.
The restructuring of its debts will not only allow MARA to make the Company debt free but also offer an opportunity to have a 45% residual revenue share once DBD recovers its costs, certain management fees, and debt amounts. In the meanwhile, as per terms of the agreement, MARA will have to continue handover any recoveries to DBD till the Restructuring Agreement is completed. The Restructuring Agreement is expected to be completed in Q3 2017 or Q4 2017.
MARA will continue to retain ownership of its other remaining portfolios and will continue enforcing those portfolios.
MARA's agreement with investors for convertible debt financing
Doug also disclosed that MARA had entered into a separate agreement with investors to raise a minimum of $3.5 million, and up to a maximum of $5.5 million via convertible debt financing. The funds raised via the convertible debt financing would be used to help identifying strategic alternatives for the Company and for other business requirements. The fresh capital will be issued to the Company provided MARA manages to restructure its payables and the DBD debt as per the levels mandated by the new investors.
Because of MARA's agreement with DBD and the new investors, the Company would be able to reduce its operating cash requirements and the infusion of fresh capital would ensure that MARA has a strong balance sheet.
Doug also shared that the Company is looking at continuing in the IP Monetization business and in the meanwhile it is exploring other strategic alternatives including potential alternative business directions to expand operations and maximize business' potential for growth.
About Marathon Patent Group
Los Angeles, California based MARA is a patent and patent rights acquisition and licensing Company. MARA buys high-quality patents and manages IP rights from a variety of sources, including large and small corporations, universities and other IP owners. The Company focuses on IP acquisition and management globally. MARA's commercialization division focuses on the entire commercialization lifecycle which includes discovering opportunities, performing due diligence, providing capital, managing development, protecting and developing IP, assisting in execution of the business plan, and realizing shareholder value.
Last Close Stock Review
On Wednesday, August 16, 2017, Marathon Patent's stock closed the trading session at $0.26 with a total volume of 923.24 thousand shares traded. The stock currently has a market cap of $6.10 million.
Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charter holder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: (917) 341.4653
Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
© 2017 Accesswire. All Rights Reserved.